Physician profile
David Kent Hansen
NPI 1780884247
$2,028.20
in general payments reported to CMS, 2019-2025
8 companies · $903 in 2025
The $903 reported for 2025 was more than what 95% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $25.40 · 2021: $551 · 2022: $337 · 2023: $169 · 2024: $43.17 · 2025: $903.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $459 · Travel and Lodging: $450 · Food and Beverage: $205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $459.02 |
| Travel and Lodging | $450.41 |
| Food and Beverage | $205.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $1,237.36 | 2021-2025 | Opalescence |
| Patterson Companies, INC. | $450.41 | 2025 | |
| A-Dec, INC. | $162.07 | 2025 | |
| Dentsply Sirona INC | $112.29 | 2020-2022 | |
| Voco America INC. | $25.51 | 2021-2024 | Admira Fusion, Profluorid L, Grandio So |
| Straumann USA LLC | $15.17 | 2024 | |
| Solventum Corporation | $14.38 | 2024 | 3m Scotchbond, 3m Relyx, 3m Espe Filtek Supreme Ultra Universal Restorative |
| Gc America INC. | $11.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.